Love FOLD but today was options expiration and most likely the reason for the volume surge.
Still these guys will make they're shareholders mucho dinero.
Yeah. Look at how scared investors are today. FOLD up over 3%.
JC is one of the smartest people in biotech and you know nothing about how the wealthy manage they're money.
Rookie, they sell for many reasons. Learn before you post.
Hey MH, old QCOR penman! What's going on?
I bought AMRI on tip from a friend. You in too?
Agreed with the lawyers. Buying stocks is risky and losses happen all of the time but they also reward big when selected correctly. What a bunch of spineless pricks.
I remember when they were screaming about FB's lock expiration and how the stock would get killed because of it. If memory serves, the stock was around 30 at the time and the was no pullback when the expiation date came.
When a company is great and has far superior technology, there are always buyers underneath the market. GPRO will prove that.
For a decade I watched people like you scream how over valued AMZN was as it soared higher and higher and finally after all of that time, AMZN has pulled back. Well GPRO not only makes money but has barely scratched the surface of it's growth potential so don't think for a minute that this run is over.
This stock will continue to defy all naysayers and while the road may be bumpy, it will be trading over 10 by year's end.
You freaking novice. Look at the price of biotechs who have yet to get to Phase 3 trials and most of them are under 5 bucks. Other than some real special circumstances, this is the case but you're to lazy toactually do some research before you post. A good Phase 3 and we get 6 bucks real fast.
I am long but tend to agree with you.
CYTR is now the king or "previously published" data. Gimme something I can chew on.
I have to guess that if Doxil did 500 million then Aldox, being so much less toxic, will double those sales easily.